title: Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?
abstract: Dietary intervention, phosphate (P) removal during dialysis and, especially, phosphate binders are current methods for the management of hyperphosphataemia. Ideally, the amount of P absorbed from the diet should equal the amount of P removed during dialysis, and this must occur in the context of an adequate protein intake. We evaluated the relationship between P intake and protein intake in 60 stable chronic uraemic patients (mean age 55+/-15 years, 25% diabetics, 68% males) on standard 4 h haemodialysis. The dietary counselling was relatively free for protein and calories. Nutrient intake was recorded during a 5 day period, and average daily ingestion of P and proteins was calculated using a computerized diet analysis system. A highly significant correlation was observed between protein and P intake. The mean daily ingestion of P and proteins was 998+/-316 mg and 64+/-19 g (1+/-0.4 g/kg/day), respectively. For an optimal protein diet of 1-1.2 g/kg/day, the P intake was 778-1444 mg. The amount of P removed by haemodialysis, extrapolated to an average week, is 250-300 mg/day. Since approximately 40% of P ingested is absorbed from the gut by uraemic patients treated with intestinal P binders, 750 mg of P intake should be the critical value above which a positive balance of P may occur. This value corresponds to a protein intake of 45-50 g per day (>0.8 g/kg body weight/day for a 60 kg patient). In patients undergoing standard chronic haemodialysis, a neutral P balance is difficult to achieve, despite phosphate binder therapy, when protein intake is >50 g. Additional protein restriction, in order to obtain a neutral balance, may impose the risk of protein malnutrition.
authors.affiliation: Nephrology Service, Hospital Universitario Canarias, Santa Cruz de Tenerife, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Rufino
authors.forename: E
authors.initials: E
authors.lastname: de Bonis
authors.forename: M
authors.initials: M
authors.lastname: Martín
authors.forename: S
authors.initials: S
authors.lastname: Rebollo
authors.forename: B
authors.initials: B
authors.lastname: Martín
authors.forename: R
authors.initials: R
authors.lastname: Miquel
authors.forename: M
authors.initials: M
authors.lastname: Cobo
authors.forename: D
authors.initials: D
authors.lastname: Hernández
authors.forename: A
authors.initials: A
authors.lastname: Torres
authors.forename: V
authors.initials: V
authors.lastname: Lorenzo
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D004044:Dietary Proteins / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010758:Phosphorus / Q000097:blood*; D016226:Phosphorus, Dietary / Q000008:administration & dosage*; D011488:Protein Deficiency / Q000517:prevention & control*; D006435:Renal Dialysis
chemical_list: D004044:Dietary Proteins; D016226:Phosphorus, Dietary; D010758:Phosphorus